₹7,250 crore) advance to Moderna for its booster vaccine in India, sources privy to the development said.Cipla's latest communication to the government, dated May 29, follows a high-level meeting held recently during which it was discussed that Moderna has proposed to launch a single-dose vaccine for the Indian market, for which, they were in discussion with Cipla and other Indian companies.It was also discussed in that meeting that orders for supply of the vaccine in 2022 may be placed with Moderna expeditiously and that Cipla has evinced interest to procure 50 million doses from Moderna for 2022.
It was also suggested that Cipla may be asked to submit their specific requests to the government on their request for a "confirmation from the.